The global cardiac valve market is projected to grow from USD 8.661 billion in 2025 to USD 14.97 billion by 2035, exhibiting a CAGR of 5.62%. This growth is driven by the increasing prevalence of heart valve disorders, aging populations, and advancements in minimally invasive surgical technologies. Key players like Edwards Lifesciences, Medtronic, Abbott Laboratories, and Boston Scientific are focusing on innovation, regulatory approvals, and strategic collaborations to meet rising demand.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Cardiac Valve Market 2026 - 2035 Major Key Players: Edwards
The global cardiac valve market is projected to grow from USD 8.661 billion in 2025 to USD 14.97 billion by 2035, exhibiting a CAGR of 5.62%. This growth is driven by the increasing prevalence of heart valve disorders, aging populations, and advancements in minimally invasive surgical technologies. Key players like Edwards Lifesciences, Medtronic, Abbott Laboratories, and Boston Scientific are focusing on innovation, regulatory approvals, and strategic collaborations to meet rising demand.